Pasar al contenido principal

TRANSMITOFAGIA ENTRE ASTROCITOS Y NEURONAS: UNA NUEVA FORMA DE COMUNICACION ENTRE NEURONA Y GLIA EN LA ENFERMEDAD DE HUNTINGTON?

RTI2018-094374-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification of bip as a cb1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain

  • Costas-Insua, Carlos
  • Moreno, Estefanía
  • Maroto, Irene B.
  • Ruiz-Calvo, Andrea
  • Bajo-Grañeras, Raquel
  • Martín-Gutiérrez, David
  • Diez-Alarcia, Rebeca
  • Vilaró, Maria Teresa
  • Cortés, Roser
  • García-Font, Nuria
  • Martín, Ricardo
  • Espina, Marc
  • Botta, Joaquín
  • Ginés, Silvia
  • McCormick, Peter J.
  • Sánchez-Prieto, José
  • Galve-Roperh, Ismael
  • Mengod Los Arcos, Guadalupe
  • Urigüen, Leyre
  • Marsicano, Giovanni
  • Bellocchio, Luigi
  • Canela, Enric I.
  • Casadó, Vicent
  • Rodríguez-Crespo, Ignacio
  • Guzmán, Manuel
Cannabinoids, the bioactive constituents of cannabis, exert a wide array of effects on the brain by engaging Type 1 cannabinoid receptor (CB1R). Accruing evidence supports that cannabinoid action relies on context-dependent factors, such as the biological characteristics of the target cell, suggesting that cell population-intrinsic molecular cues modulate CB1R-dependent signaling. Here, by using a yeast two-hybrid-based high-throughput screening, we identified BiP as a potential CB1R-interacting protein. We next found that CB1R and BiP interact specifically in vitro, and mapped the interaction site within the CB1R C-terminal (intracellular) domain and the BiP C-terminal (substrate-binding) domain-a. BiP selectively shaped agonist-evoked CB1R signaling by blocking an "alternative" Gq/11 protein-dependent signaling module while leaving the "classical" Gi/o protein-dependent inhibition of the cAMP pathway unaffected. In situ proximity ligation assays conducted on brain samples from various genetic mouse models of conditional loss or gain of CB1R expression allowed to map CB1R-BiP complexes selectively on terminals of GABAergic neurons. Behavioral studies using cannabinoid- treated male BiP1/2 mice supported that CB1R-BiP complexes modulate cannabinoid-evoked anxiety, one of the most frequent undesired effects of cannabis. Together, by identifying BiP as a CB1R-interacting protein that controls receptor function in a signaling pathway- and neuron population-selective manner, our findings may help to understand the striking context-dependent actions of cannabis in the brain., This work was supported by Spanish Ministerio de Ciencia e Innovación Grants RTI2018-095311-B-I00 to M.G., SAF-2017-87629-R to E.I.C. and V.C., PID2019-106404RB-I00 to L.U., BFU 2017-83292-R to J.S.-P., and RTI2018-094374-B-I00 to S.G.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas Grant PI2018/01 to M.G., S.G., and G. Mengod; and UK Research and Innovation Biotechnology and Biological Sciences Research Council Grant BB/R006946/1 to P.J.M., L.B., and G. Marsicano were supported by Institut National de la Santé et de la Recherche Médicale. C.C.-I. and I.B.M. were supported by contracts from Spanish Ministerio de Universidades (Formación de Profesorado Universitario Program, references FPU16/02593 and FPU15/01833, respectively). R.B.-G. was supported by a contract from Spanish Ministerio de Ciencia e Innovación Juan de la Cierva Program., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Placental transfer of NMDAR antibodies causes reversible alterations in mice

  • García-Serra, Anna|||0000-0002-9609-2290
  • Radosevic, Marija
  • Pupak, Anika
  • Brito, Verónica|||0000-0002-4137-0708
  • Ríos, José|||0000-0002-0716-8784
  • Aguilar, Esther
  • Maudes, Estibaliz
  • Ariño, Helena|||0000-0003-4036-1671
  • Spatola, Marianna|||0000-0003-2548-0429
  • Mannara, Francesco
  • Pedreño, Marta
  • Joubert, Bastien
  • Ginés, Silvia
  • Planagumà i Valls, Jesús
  • Dalmau, Josep|||0000-0001-5856-2813
To determine whether maternofetal transfer of NMDA receptor (NMDAR) antibodies has pathogenic effects on the fetus and offspring, we developed a model of placental transfer of antibodies. Pregnant C57BL/6J mice were administered via tail vein patients' or controls' immunoglobulin G (IgG) on days 14-16 of gestation, when the placenta is able to transport IgG and the immature fetal blood-brain barrier is less restrictive to IgG crossing. Immunohistochemical and DiOlistic (gene gun delivery of fluorescent dye) staining, confocal microscopy, standardized developmental and behavioral tasks, and hippocampal long-term potentiation were used to determine the antibody effects. In brains of fetuses, patients' IgG, but not controls' IgG, bound to NMDAR, causing a decrease in NMDAR clusters and cortical plate thickness. No increase in neonatal mortality was observed, but offspring exposed in utero to patients' IgG had reduced levels of cell-surface and synaptic NMDAR, increased dendritic arborization, decreased density of mature (mushroom-shaped) spines, microglial activation, and thinning of brain cortical layers II-IV with cellular compaction. These animals also had a delay in innate reflexes and eye opening and during follow-up showed depressive-like behavior, deficits in nest building, poor motor coordination, and impaired social-spatial memory and hippocampal plasticity. Remarkably, all these paradigms progressively improved (becoming similar to those of controls) during follow-up until adulthood. In this model, placental transfer of patients' NMDAR antibodies caused severe but reversible synaptic and neurodevelopmental alterations. Reversible antibody effects may contribute to the infrequent and limited number of complications described in children of patients who develop anti-NMDAR encephalitis during pregnancy.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Pyk2 regulates MAMs and mitochondrial dynamics in hippocampal neurons

  • López-Molina, Laura
  • Fernández Irigoyen, Joaquín
  • Cifuentes-Díaz, Carmen
  • Alberch, Jordi
  • Girault, Jean Antoine
  • Santamaría Martínez, Enrique
  • Ginés, Silvia
  • Giralt, Albert
Pyk2 is a non-receptor tyrosine kinase enriched in hippocampal neurons, which can be activated by calcium-dependent mechanisms. In neurons, Pyk2 is mostly localised in the cytosol and dendritic shafts but can translocate to spines and/or to the nucleus. Here, we explore the function of a new localisation of Pyk2 in mitochondria-associated membranes (MAMs), a subdomain of ER-mitochondria surface that acts as a signalling hub in calcium regulation. To test the role of Pyk2 in MAMs’ calcium transport, we used full Pyk2 knockout mice (Pyk2−/−) for in vivo and in vitro studies. Here we report that Pyk2−/− hippocampal neurons present increased ER-mitochondrial contacts along with defective calcium homeostasis. We also show how the absence of Pyk2 modulates mitochondrial dynamics and morphology. Taken all together, our results point out that Pyk2 could be highly relevant in the modulation of ER-mitochondria calcium efflux, affecting in turn mitochondrial function, A.G. is a Ramón y Cajal fellow (RYC-2016¿19466) supported by a grant from Ministerio de Ciencia, Innovación y Universidades (RTI2018-094678-A-I00). RTI2018-094374-B-I00 to S.G., from Ministerio de Ciencia, Innovación y Universidades.